Prominent European electrophysiology labs and hospitals have embraced the next generation mapping system’s automation, flexibility and precision for tailoring treatment for patients with cardiac ...

The U.S. Food and Drug Administration has given sales clearance to St. Jude Medical's latest heart-mapping tools, which are used to precisely create scar tissue on the heart to fix an abnormal ...

Abbott Laboratories ABT recently announced the receipt of the FDA clearance for the EnSite X EP System with EnSite Omnipolar Technology (OT). The new system is available in the United States and ...

The EnSite Precision cardiac mapping system was developed to be used seamlessly with the existing portfolio of St. Jude Medical™ EP products, including the TactiCath Quartz Ablation Catheter System, ...

Abbott announced it has received CE Mark and approval in Australia for its new EnSite X EP System, and is launching the system throughout Europe and Australia. The EnSite X System is the only system ...

Abbott, a global healthcare leader that helps people live more fully at all stages of life, announced it has received clearance from the US Food and Drug Administration for the EnSite X EP System with ...

Abbott has scored clearance from the FDA for its latest 3D cardiac mapping platform, designed to help physicians target abnormal heart rhythms. The EnSite X EP system threads a catheter into the heart ...